A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587).

A randomized phase II trial of echinomycin, trimetrexate, and cisplatin plus etoposide in patients with metastatic nonsmall cell lung carcinoma: an Eastern Cooperative Oncology Group Study (E1587). Cancer. 1998 Jan 15; 82(2):292-300.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibiotics, Antineoplastic
Antimetabolites, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Cisplatin
Drug Administration Schedule
Echinomycin
Etoposide
Female
Humans
Infusions, Intravenous
Injections, Intravenous
Intercalating Agents
Lung Neoplasms
Male
Middle Aged
Prognosis
Quality of Life
Remission Induction
Survival Rate
Trimetrexate